BACKGROUND: Ankle arthrodesis may be achieved using the Ilizarov method. Comorbidities, such as diabetes, Charcot neuroarthropathy, osteomyelitis, leg length discrepancy, and smoking, can make an ankle fusion complex and may be associated with lower rates of healing. QUESTIONS/PURPOSES: We asked if (1) smoking and other comorbidities led to lower fusion rates, (2) time wearing the frame affected outcome, and (3) simultaneous tibial lengthening improved fusion rates. METHODS: We retrospectively studied 101 patients who underwent complex ankle fusion using the Ilizarov technique. The median time wearing the frame was 25 weeks (range, 10-65 weeks). Twenty-four patients had simultaneous tibial lengthening. The minimum followup for 91 of the 101 patients was 27 months (median, 65 months; range, 27-134 months). RESULTS: Fusion was achieved in 76 of 91 patients. Smoking was associated with a 54% rate of nonunion. Fifteen of 19 patients with Charcot neuroarthropathy achieved union but had a high rate of subsequent subtalar joint failure. Time wearing the frame did not affect union rates. Tibial lengthening did not improve ankle fusion rates. CONCLUSION: Smokers should be warned of the high risk of nonunion and we recommend they quit smoking. We also recommend surgeons recognize the higher nonunion rate in patients with Charcot neuroarthropathy. We believe tibial lengthening should not be performed to enhance healing at the fusion site. LEVEL OF EVIDENCE: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
BACKGROUND:Ankle arthrodesis may be achieved using the Ilizarov method. Comorbidities, such as diabetes, Charcot neuroarthropathy, osteomyelitis, leg length discrepancy, and smoking, can make an ankle fusion complex and may be associated with lower rates of healing. QUESTIONS/PURPOSES: We asked if (1) smoking and other comorbidities led to lower fusion rates, (2) time wearing the frame affected outcome, and (3) simultaneous tibial lengthening improved fusion rates. METHODS: We retrospectively studied 101 patients who underwent complex ankle fusion using the Ilizarov technique. The median time wearing the frame was 25 weeks (range, 10-65 weeks). Twenty-four patients had simultaneous tibial lengthening. The minimum followup for 91 of the 101 patients was 27 months (median, 65 months; range, 27-134 months). RESULTS: Fusion was achieved in 76 of 91 patients. Smoking was associated with a 54% rate of nonunion. Fifteen of 19 patients with Charcot neuroarthropathy achieved union but had a high rate of subsequent subtalar joint failure. Time wearing the frame did not affect union rates. Tibial lengthening did not improve ankle fusion rates. CONCLUSION: Smokers should be warned of the high risk of nonunion and we recommend they quit smoking. We also recommend surgeons recognize the higher nonunion rate in patients with Charcot neuroarthropathy. We believe tibial lengthening should not be performed to enhance healing at the fusion site. LEVEL OF EVIDENCE: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.
Authors: Luca Dalla Paola; Enrico Brocco; Tanja Ceccacci; Sasa Ninkovic; Sara Sorgentone; Maria Grazia Marinescu; Antonio Volpe Journal: Foot Ankle Int Date: 2009-11 Impact factor: 2.827
Authors: Mitchell S Fourman; Eugene W Borst; Eric Bogner; S Robert Rozbruch; Austin T Fragomen Journal: Clin Orthop Relat Res Date: 2013-08-29 Impact factor: 4.176
Authors: Samuel O Ewalefo; Malcolm Dombrowski; Takashi Hirase; Jorge L Rocha; Mitchell Weaver; Alex Kline; Dwayne Carney; MaCalus V Hogan Journal: Curr Rev Musculoskelet Med Date: 2018-12
Authors: Ashish B Shah; William Davis; Zachary L Littlefield; Sean Young; Bradley Alexander; Nicholas A Andrews; Ankit Khurana; Benjamin Cage; Tanvee Sinha; Gerald McGwin; Ashish Shah Journal: Indian J Orthop Date: 2022-04-25 Impact factor: 1.033
Authors: Charlotte Reinke; Sebastian Lotzien; Emre Yilmaz; Yannik Hanusrichter; Christopher Ull; Hinnerk Baecker; Thomas A Schildhauer; Jan Geßmann Journal: Arch Orthop Trauma Surg Date: 2021-01-23 Impact factor: 2.928